Crossmark

Shortcomings and missed potentials in the management of migraine patients - experiences from a specialized tertiary care center

Published Online: 2019-08-01

Published Print: 2019-12

Authors

Ziegeler, Christian

Brauns, Greta

Jürgens, Tim P.

May, Arne http://orcid.org/0000-0002-3499-1506
Funding

Funding for this research was provided by:

Novartis Pharma (This study was funded in part by an unrestricted scientific grant from Novartis to the UKE)
License Information

Text and Data Mining valid from 2019-08-01

Version of Record valid from 2019-08-01
More Information

Article History

Received: 19 June 2019

Accepted: 23 July 2019

First Online: 1 August 2019

Ethics approval and consent to participate

: This study was approved by the local ethics committee of the chamber of physicians of Hamburg, Germany (PV 3185) and patients gave written informed consent according to the Declaration of Helsinki.

: None regarding the content of this paper.CZ received speaker honoraria and from Novartis, Teva, Allergan and Lilly and received consulting fees from Novartis and Teva.TPJ received honoraria and consulting fees from Autonomic Technologies, Inc., Allergan, Lilly, Novartis and TEVA. He also received travel grants from Allergan.GB and AM report no competing interests.

Document is current